Mei‐Ling Nan
Impact in
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- Immunology top 5%
- interferon and immune responses
- Immune Response and Inflammation
Papers in
-
- interferon and immune responses 6
- Immune Response and Inflammation 1
-
- Gut microbiota and health 1
- Co-authors
- Pei‐Hui Wang (8 shared papers)Chengjiang Gao (6 shared papers)Lulu Han (6 shared papers)Yi Zheng (6 shared papers)Meng‐Wei Zhuang (4 shared papers)Jian Deng (5 shared papers)Jing Zhang (3 shared papers)Peng Zhan (2 shared papers)
- Journals
- Journal of Medical Virology (4 papers)Signal Transduction and Targeted Therapy (2 papers)Advances in experimental medicine and biology (1 paper)Frontiers in Cellular and Infection Microbiology (1 paper)
- Partner nations
- ChinaNigeriaUnited States
In The Last Decade
Mei‐Ling Nan
8 papers receiving 758 citations
Peers
Comparison fields: 5 of 53
- Infectious Diseases 363
- Immunology 358
- Animal Science and Zoology 25
- Molecular Biology 105
- Epidemiology 47
Countries citing papers authored by Mei‐Ling Nan
This map shows the geographic impact of Mei‐Ling Nan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mei‐Ling Nan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mei‐Ling Nan more than expected).
Fields of papers citing papers by Mei‐Ling Nan
This network shows the impact of papers produced by Mei‐Ling Nan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mei‐Ling Nan. The network helps show where Mei‐Ling Nan may publish in the future.
Co-authors
The 25 scholars most cited alongside Mei‐Ling Nan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 257 | |
| 2 | 2021 | 202 | |
| 3 | 2022 | 133 | |
| 4 | 2022 | 73 | |
| 5 | 2019 | 46 | |
| 6 | 2023 | 30 | |
| 7 | 2023 | 20 | |
| 8 | 2022 | 8 |
About Mei‐Ling Nan
Mei‐Ling Nan is a scholar working on Immunology, Molecular Biology, Nuclear Energy and Engineering, Waste Management and Disposal and Infectious Diseases, having authored 8 papers that have together received 769 indexed citations. Recurring topics across this work include interferon and immune responses (6 papers), Gut microbiota and health (1 paper) and Immune Response and Inflammation (1 paper). The work is most often cited by research in Infectious Diseases (363 citations), Immunology (358 citations), Animal Science and Zoology (25 citations), Molecular Biology (105 citations) and Epidemiology (47 citations). Mei‐Ling Nan has collaborated with scholars based in China, Nigeria and United States. Frequent co-authors include Pei‐Hui Wang, Chengjiang Gao, Lulu Han, Yi Zheng, Meng‐Wei Zhuang, Jian Deng, Jing Zhang, Peng Zhan, Xinyong Liu and Dongwei Kang. Their work appears in journals such as Journal of Medical Virology, Signal Transduction and Targeted Therapy, Advances in experimental medicine and biology and Frontiers in Cellular and Infection Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.